Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Serafin®

K-Number: K232074 · 2024-02-22

ApplicantTns Co., Ltd.
Decision Date2024-02-22
Product CodeNXC
Advisory CommitteeDE
DecisionSubstantially Equivalent

Device Summary

Serafin® is the device name listed in this FDA 510(k) record. The listed applicant is Tns Co., Ltd.. It received FDA 510(k) clearance on 2024-02-22 under 510(k) number K232074. The device is classified under product code NXC. It was reviewed by the DE advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Serafin®?

Serafin® is a medical device that received FDA 510(k) clearance on 2024-02-22. The listed applicant is Tns Co., Ltd.. The 510(k) number is K232074.

When did Serafin® receive FDA 510(k) clearance?

Serafin® received FDA 510(k) clearance on 2024-02-22, under 510(k) number K232074.

Who is the listed applicant for Serafin®?

The FDA 510(k) record lists Tns Co., Ltd. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Serafin®?

The FDA product code for Serafin® is NXC.

Other records listing Tns Co., Ltd. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Related Devices (Code: NXC)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.